NOVOTHELIUM, LLC

Medtech

Acellular nipple areolar graft created from decellularized donor tissue for breast reconstruction

Grants
$274K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
2 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Novel Scaffold for Nipple Areolar Regeneration$274,194
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1182INIA BIOSCIENCES, INC.—$200K
1183INTRINSIC LIFESCIENCES, LLC——
1184CubeWorks, Inc.—$18M
1185NOVOTHELIUM, LLC——
1186Jana Care, Inc.—$33M
1187OXOS MEDICAL, INC.—$18M
1188MEDICAL ENGINEERING INNOVATIONS, LLC—$7.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 4

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.